Oral Cancer Screening
OralID is manufactured by Forward Science, a company that was founded with the vision to create a simpler, efficient and more affordable oral screening device that can save more lives.
OralID uses the same proven fluorescence technology as other oral exam devices, but costs up to fifty percent less than its closest competitor (and only one-third of another competitor). However, unlike any other device on the market, OralID has no per-patient cost during use.
The combination of OralID's comparatively low initial investment cost and a lack of disposables mean OralID is the oral exam device that every clinician deserves to wield in the fight against oral cancer.
Did you know that ...
40 percent of oral cancers are found in patients who do not present with any of the traditional risk factors or any other significant lifestyle risks?
The traditional risk factors of oral cancer include:
- Previous history of oral cancer
- Over 40 years of age
- Smokeless tobacco
This means all patients, regardless of age and lifestyle, need an oral exam that looks closely for abnormal tissue. (Please see the Trends tab for more detailed information about why this is.)
Here are some statistics to consider:
- Oral cancer kills one American every hour.
- Approximately 42,000 people in the United States will be newly diagnosed with oral cancer in 2013.
- In 2013, among the 42,000 diagnosed with oral cancer in the United States, 18,000 will not be alive in five years.
- Oral cancer's incidence rate has increased the last five years in a row.
- In 2007, oral cancer's incidence increased by 11 percent.
- The mortality rate for oral cancer has not changed significantly in three decades
- Oral cancer's high mortality rate is due to late-stage discovery (Stage III and IV).
- The mortality rate for oral cancer is higher than the rates for cervical cancer, Hodgkin's lymphoma, laryngeal cancer, testicular cancer, thyroid cancer and skin cancer.
When found at an early stage of development (Stage I and II), oral cancers have an 80 to 90 percent survival rate. The problem is that the majority of oral cancers are found in late stages (Stage II and IV), resulting in a mortality rate of 43 percent at a five-year diagnosis (for all stages combined).
Why is oral cancer found so late?
It is not because oral cancer is hard to discover or dignose, it is because of a lack of public awareness and the simple fact that there is not a comprehensive program to opportunistically screen for the disease.
“A COE (Clinical Oral Examination) of mucosal lesions generally is not predictive of their histologic diagnosis. The fact that OSCCs often are diagnosed at an advanced stage emphasized the need for improving the COE and the need to develop adjuncts to assist in oral mucosal lesion detection and diagnosis.”